Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Sawyers

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Cancer Surveys|January 1, 1992
The bcr-abl gene in chronic myelogenous leukaemiaC L Sawyers
Leukemia & Lymphoma|January 1, 1993
The role of myc in transformation by BCR-ABLC L Sawyers
Science (New York, N.Y.)|December 6, 2001
Research on resistance to cancer drug GleevecC L Sawyers
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2001
Cancer treatment in the STI571 era: what will change?C L Sawyers
Leukemia & Lymphoma|January 1, 1993
Molecular consequences of the BCR-ABL translocation in chronic myelogenous leukemiaC L Sawyers
Seminars in Hematology|August 30, 2001
Implications of signal transduction inhibition for the treatment of chronic myeloid leukemiaC L Sawyers
Bailliere'S Clinical Haematology|June 1, 1997
Signal transduction pathways involved in BCR-ABL transformationC L Sawyers
Leukemia Research|January 28, 1999
Molecular abnormalities in myeloid leukemias and myelodysplastic syndromesC L Sawyers
Seminars in Hematology|August 30, 2001
Molecular studies in chronic myeloid leukemia patients treated with tyrosine kinase inhibitorsC L Sawyers
The New England Journal of Medicine|April 29, 1999
Chronic myeloid leukemiaC L Sawyers
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Cancer Surveys|January 1, 1992
The bcr-abl gene in chronic myelogenous leukaemiaC L Sawyers
Leukemia & Lymphoma|January 1, 1993
The role of myc in transformation by BCR-ABLC L Sawyers
Science (New York, N.Y.)|December 6, 2001
Research on resistance to cancer drug GleevecC L Sawyers
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2001
Cancer treatment in the STI571 era: what will change?C L Sawyers
Leukemia & Lymphoma|January 1, 1993
Molecular consequences of the BCR-ABL translocation in chronic myelogenous leukemiaC L Sawyers
Seminars in Hematology|August 30, 2001
Implications of signal transduction inhibition for the treatment of chronic myeloid leukemiaC L Sawyers
Bailliere'S Clinical Haematology|June 1, 1997
Signal transduction pathways involved in BCR-ABL transformationC L Sawyers
Leukemia Research|January 28, 1999
Molecular abnormalities in myeloid leukemias and myelodysplastic syndromesC L Sawyers
Seminars in Hematology|August 30, 2001
Molecular studies in chronic myeloid leukemia patients treated with tyrosine kinase inhibitorsC L Sawyers
The New England Journal of Medicine|April 29, 1999
Chronic myeloid leukemiaC L Sawyers
Pageof 6